Literature DB >> 320995

A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate.

D V Stevanovic, L Wilson, C G Sparkes.   

Abstract

Clobetasone butyrate ointment has been shown to be more effective in treating psoriasis and eczema than flurandrenolone ointment yet to cause less epidermal thinning in a human experimental model. This is an indication that the clinical activity of topical glucocorticoids may not necessarily be inseparable from their propensity to cause atrophy of the skin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320995     DOI: 10.1111/j.1365-2133.1977.tb05187.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

2.  Topical corticosteroids: clinical pharmacology and therapeutic use.

Authors:  J A Miller; D D Munro
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

3.  Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers.

Authors:  A Kecskés; P Jahn; H Wendt; L Lange; R K Kuhlmann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Epidermal thinning: evaluation of commercial corticosteroids.

Authors:  R Wrench
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.